VEDP's Supply Chain Optimization Program Receives NASBITE International Program Excellence Award

Eric Arocho is associate vice president at Eli Lilly and Company and the site lead on the company’s facility in Goochland County, Virginia - announced last year. The Goochland facility, expected to be completed within the next five years, will produce both critical drug components and finished medicines to support Lilly’s emerging bioconjugate platform and monoclonal antibody portfolio.

Virginia’s cities, counties, and towns represent a wide range of living situations, with a location to support any lifestyle.

With recent investments in biopharma manufacturing, Virginia is meeting the moment with a major push to build its talent pipeline, launching new training programs and a dedicated workforce center to prepare workers for advanced manufacturing roles. As reshoring accelerates, the Commonwealth is positioning itself not just as a production hub—but as a leader in workforce readiness. 

Merck, Eli Lilly, Astra Zenec and more have made investments to expand in Virginia, signalling a broader surge in U.S.-based biopharma manufacturing as major drugmakers invest billions to bring production stateside. Driven by pandemic-era supply chain risks and new policy incentives, a nationwide reshoring wave is rapidly gaining momentum.

Virginia’s cities, counties, and towns represent a wide range of living situations, with a location to support any lifestyle.

Best Medical International, a Virginia-based cancer treatment manufacturer, is expanding its global reach with support from VEDP. The Commonwealth's strategic logistics advantages and targeted international outreach continue to position Best Medical for sustained global growth.

Across Virginia, local life sciences ecosystems are helping researchers connect with the funding and facilities they need to grow.

Recent major biopharmaceutical announcements have sent a clear signal from the industry: Virginia is the future of biopharma manufacturing.